Table of Contents for the Digital Edition of Pharmacy & Therapeutics - February 2011 Pharmacy & Therapeutics - February 2011 Contents Prescription: Washington Editorial Medication Errors New Drugs/Drug News/ New Medical Devices Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke American Society of Hematology, 52nd Annual Meeting and Exposition Pharmaceutical Approval Update Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) Pharmacy & Therapeutics - February 2011 Pharmacy & Therapeutics - February 2011 - Pharmacy & Therapeutics - February 2011 (Page Cover1) Pharmacy & Therapeutics - February 2011 - Contents (Page 52) Pharmacy & Therapeutics - February 2011 - Contents (Page 53) Pharmacy & Therapeutics - February 2011 - Contents (Page 54) Pharmacy & Therapeutics - February 2011 - Contents (Page 55) Pharmacy & Therapeutics - February 2011 - Contents (Page 56) Pharmacy & Therapeutics - February 2011 - Prescription: Washington (Page 57) Pharmacy & Therapeutics - February 2011 - Prescription: Washington (Page 58) Pharmacy & Therapeutics - February 2011 - Prescription: Washington (Page 59) Pharmacy & Therapeutics - February 2011 - Editorial (Page 60) Pharmacy & Therapeutics - February 2011 - Editorial (Page 61) Pharmacy & Therapeutics - February 2011 - Medication Errors (Page 62) Pharmacy & Therapeutics - February 2011 - Medication Errors (Page 63) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 64) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 65) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 66) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 67) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 68) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 69) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 70) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 73) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 74) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 75) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 76) Pharmacy & Therapeutics - February 2011 - New Drugs/Drug News/ New Medical Devices (Page 77) Pharmacy & Therapeutics - February 2011 - Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain (Page 78) Pharmacy & Therapeutics - February 2011 - Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain (Page 79) Pharmacy & Therapeutics - February 2011 - Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain (Page 80) Pharmacy & Therapeutics - February 2011 - Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain (Page 81) Pharmacy & Therapeutics - February 2011 - Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain (Page 82) Pharmacy & Therapeutics - February 2011 - Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain (Page 83) Pharmacy & Therapeutics - February 2011 - Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain (Page 84) Pharmacy & Therapeutics - February 2011 - Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain (Page 85) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 86) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 87) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 88) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 89) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 90) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 91) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 92) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 93) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 94) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 95) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 96) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 97) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 98) Pharmacy & Therapeutics - February 2011 - New Options in Anticoagulation for the Prevention of Venous Thromboembolism and Stroke (Page 99) Pharmacy & Therapeutics - February 2011 - American Society of Hematology, 52nd Annual Meeting and Exposition (Page 100) Pharmacy & Therapeutics - February 2011 - American Society of Hematology, 52nd Annual Meeting and Exposition (Page 101) Pharmacy & Therapeutics - February 2011 - American Society of Hematology, 52nd Annual Meeting and Exposition (Page 102) Pharmacy & Therapeutics - February 2011 - American Society of Hematology, 52nd Annual Meeting and Exposition (Page 103) Pharmacy & Therapeutics - February 2011 - Pharmaceutical Approval Update (Page 104) Pharmacy & Therapeutics - February 2011 - Pharmaceutical Approval Update (Page 105) Pharmacy & Therapeutics - February 2011 - Pharmaceutical Approval Update (Page 106) Pharmacy & Therapeutics - February 2011 - Pharmaceutical Approval Update (Page 107) Pharmacy & Therapeutics - February 2011 - Pharmaceutical Approval Update (Page 108) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A-Cover1) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A-Cover2) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A1) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A2) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A3) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A4) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A5) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A6) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A7) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A8) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A9) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A10) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A11) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A12) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A13) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A14) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A15) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A16) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A17) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A18) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A19) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A20) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A21) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A22) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A23) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A24) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A25) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A26) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A27) Pharmacy & Therapeutics - February 2011 - Product Profiler: Oleptro™ (trazodone hydrochloride) Extended-Release Tablets (Page A28) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B-Cover1) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B-Cover2) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B1) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B2) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B3) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B4) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B5) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B6) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B7) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B8) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B9) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B10) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B11) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B12) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B13) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B14) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B15) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B16) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B17) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B18) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B19) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B20) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B21) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B22) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B23) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B24) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B25) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B26) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B27) Pharmacy & Therapeutics - February 2011 - Product Profiler: Abstral® (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain) (Page B28) http://www.nxtbook.com/nxtbooks/medimedia/pt_201202 http://www.nxtbook.com/nxtbooks/medimedia/pt_201201 http://www.nxtbook.com/nxtbooks/medimedia/pt_201112 http://www.nxtbook.com/nxtbooks/medimedia/pt_201111 http://www.nxtbook.com/nxtbooks/medimedia/pt_201110 http://www.nxtbook.com/nxtbooks/medimedia/pt_201109 http://www.nxtbook.com/nxtbooks/medimedia/pt_201108 http://www.nxtbook.com/nxtbooks/medimedia/pt_201107 http://www.nxtbook.com/nxtbooks/medimedia/pt_201106 http://www.nxtbook.com/nxtbooks/medimedia/pt_201105 http://www.nxtbook.com/nxtbooks/medimedia/pt_201104 http://www.nxtbook.com/nxtbooks/medimedia/pt_201103 http://www.nxtbook.com/nxtbooks/medimedia/pt_201102 http://www.nxtbook.com/nxtbooks/medimedia/pt_201101 http://www.nxtbook.com/nxtbooks/medimedia/pt_201012 http://www.nxtbook.com/nxtbooks/medimedia/pt_201011 http://www.nxtbook.com/nxtbooks/medimedia/pt_201010 http://www.nxtbook.com/nxtbooks/medimedia/pt_201009 http://www.nxtbook.com/nxtbooks/medimedia/pt_201008 http://www.nxtbook.com/nxtbooks/medimedia/pt_201007 http://www.nxtbook.com/nxtbooks/medimedia/pt_201006 http://www.nxtbook.com/nxtbooks/medimedia/pt_201005 http://www.nxtbook.com/nxtbooks/medimedia/pt_201004 http://www.nxtbook.com/nxtbooks/medimedia/pt_201003 http://www.nxtbook.com/nxtbooks/medimedia/pt_201002 http://www.nxtbook.com/nxtbooks/medimedia/pt_201001 http://www.nxtbook.com/nxtbooks/medimedia/pt_200912 http://www.nxtbook.com/nxtbooks/medimedia/pt_200911 http://www.nxtbook.com/nxtbooks/medimedia/pt_200910 http://www.nxtbook.com/nxtbooks/medimedia/pt_200909 http://www.nxtbook.com/nxtbooks/medimedia/pt_200908 http://www.nxtbook.com/nxtbooks/medimedia/pt_200907 http://www.nxtbook.com/nxtbooks/medimedia/pt_200906 http://www.nxtbook.com/nxtbooks/medimedia/pt_200905 http://www.nxtbook.com/nxtbooks/medimedia/pt_200904 http://www.nxtbook.com/nxtbooks/medimedia/pt_200903 http://www.nxtbook.com/nxtbooks/medimedia/pt_200902 http://www.nxtbook.com/nxtbooks/medimedia/pt_200901 http://www.nxtbook.com/nxtbooks/medimedia/pt_200812 http://www.nxtbook.com/nxtbooks/medimedia/pt_200811 http://www.nxtbook.com/nxtbooks/medimedia/pt_200810 http://www.nxtbook.com/nxtbooks/medimedia/pt_200809 http://www.nxtbook.com/nxtbooks/medimedia/pt_200808 http://www.nxtbook.com/nxtbooks/medimedia/pt_200807 http://www.nxtbook.com/nxtbooks/medimedia/pt_200806 http://www.nxtbook.com/nxtbooks/medimedia/pt_200805 http://www.nxtbook.com/nxtbooks/medimedia/pt_200804 http://www.nxtbook.com/nxtbooks/medimedia/pt_200803 http://www.nxtbook.com/nxtbooks/medimedia/pt_200802 http://www.nxtbook.com/nxtbooks/medimedia/pt_200801 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.